Literature DB >> 1377708

Multiple sclerosis: immunological findings and possible implications for therapy.

R Q Hintzen1, C H Polman, C J Lucas, R A van Lier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1377708     DOI： 10.1016/0165-5728(92)90169-l

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN： 0165-5728            Impact factor:   3.478


× No keyword cloud information.
  5 in total

1.  Correlation between interferon production and clinical disease activity in patients with multiple sclerosis.

Authors:  M Dettke; P Scheidt; H Prange; H Kirchner
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

Review 2.  FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.

Authors:  A W Thomson; P B Carroll; J McCauley; J Woo; K Abu-Elmagd; T E Starzl; D H Van Thiel
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Lymphocytes and macrophages outnumber oligodendroglia in normal fish spinal cord.

Authors:  A J Dowding; J Scholes
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

4.  Detection of a LFA-1-like epitope on the surface of erythrocytes infected with a strain of Plasmodium falciparum.

Authors:  F Tacchini-Cottier; J N Lou; D J Roberts; A M Garcia; G E Grau
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

5.  Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.

Authors:  B Lemster; L L Huang; W Irish; J Woo; P B Carroll; K Abu-Elmagd; H R Rilo; N Johnson; R Russell-Hall; J J Fung
Journal:  Autoimmunity       Date:  1994       Impact factor: 2.815
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.